
BiVacor wins FDA breakthrough nod for Total Artificial Heart
BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.
BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.
Non-Invasive Histotripsy Technology Authorized Under Unmet Clinical Needs Pathway for Liver Tumor Treatment
First-of-its-Kind Retrievable Stent Gains Approval for Treating Challenging Below-the-Knee Peripheral Artery Disease
Mass General Brigham researchers are shining a powerful new light into the viral darkness with the development of Luminescence CAscade-based Sensor (LUCAS), a rapid, portable, highly-sensitive diagnostic tool for processing complex biological samples.